Approved for the treatment of GERD, the proton pump inhibitor drug Dexilant may increase the risk for debilitating kidney disorders, including end-stage renal disease. https://t.co/6PMuIgjeuK

Approved for the treatment of GERD, the proton pump inhibitor drug Dexilant may increase the risk for debilitating kidney disorders, including end-stage renal disease. https://t.co/6PMuIgjeuK

— Rosen Injury Lawyers (@roseninjurylaw) April 9, 2018

from Twitter : https://twitter.com/roseninjurylaw